STOCK TITAN

[SCHEDULE 13G] Verastem, Inc. SEC Filing

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13G
Rhea-AI Filing Summary

Point72 discloses 6.1 % passive stake in Verastem (VSTM)

Schedule 13G dated 25 Jul 2025 reveals that Point72 Asset Management LP, its general partner Point72 Capital Advisors Inc., and founder Steven A. Cohen jointly hold 3,338,419 Verastem common shares—6.1 % of the outstanding class. The shares are owned through Point72 Associates, with Cubist Systematic Strategies acting as sub-advisor. All voting and dispositive authority is shared; none is held solely. The filing is under Rule 13d-1(b)/(c), signifying a passive investment, and includes a certification that the stake was not acquired to influence control.

Jason M. Colombo signed on behalf of all reporting persons on 28 Jul 2025. No derivatives or additional security classes are mentioned.

  • Shares owned: 3.34 M
  • Percent of class: 6.1 %
  • Reporting persons: Point72 Asset Management LP, Point72 Capital Advisors Inc., Steven A. Cohen
  • Intent: Passive (Schedule 13G)

Point72 rivela una partecipazione passiva del 6,1% in Verastem (VSTM)

Il modulo Schedule 13G datato 25 luglio 2025 mostra che Point72 Asset Management LP, il suo general partner Point72 Capital Advisors Inc. e il fondatore Steven A. Cohen detengono congiuntamente 3.338.419 azioni ordinarie di Verastem, pari al 6,1% della classe azionaria in circolazione. Le azioni sono possedute tramite Point72 Associates, con Cubist Systematic Strategies che agisce come sub-consulente. Tutti i diritti di voto e di disposizione sono condivisi; nessuno è detenuto in modo esclusivo. La comunicazione è effettuata ai sensi della Regola 13d-1(b)/(c), indicando un investimento passivo, e include una certificazione che la partecipazione non è stata acquisita per influenzare il controllo.

Jason M. Colombo ha firmato per conto di tutte le persone segnalanti il 28 luglio 2025. Non sono menzionati derivati o altre classi di titoli.

  • Azioni possedute: 3,34 milioni
  • Percentuale della classe: 6,1%
  • Persone segnalanti: Point72 Asset Management LP, Point72 Capital Advisors Inc., Steven A. Cohen
  • Intento: Passivo (Schedule 13G)

Point72 revela una participación pasiva del 6,1 % en Verastem (VSTM)

El Schedule 13G fechado el 25 de julio de 2025 muestra que Point72 Asset Management LP, su socio general Point72 Capital Advisors Inc. y el fundador Steven A. Cohen poseen conjuntamente 3.338.419 acciones comunes de Verastem, que representan el 6,1 % de la clase en circulación. Las acciones son propiedad de Point72 Associates, con Cubist Systematic Strategies actuando como subasesor. Toda la autoridad de voto y disposición es compartida; ninguna es exclusiva. La presentación se realiza bajo la Regla 13d-1(b)/(c), indicando una inversión pasiva, e incluye una certificación de que la participación no fue adquirida para influir en el control.

Jason M. Colombo firmó en nombre de todas las personas informantes el 28 de julio de 2025. No se mencionan derivados ni otras clases de valores.

  • Acciones poseídas: 3,34 millones
  • Porcentaje de la clase: 6,1 %
  • Personas informantes: Point72 Asset Management LP, Point72 Capital Advisors Inc., Steven A. Cohen
  • Intención: Pasiva (Schedule 13G)

Point72, Verastem(VSTM)에 대한 6.1% 수동 지분 공개

2025년 7월 25일자 Schedule 13G에 따르면 Point72 Asset Management LP, 일반 파트너인 Point72 Capital Advisors Inc., 창립자 Steven A. Cohen이 공동으로 3,338,419주의 Verastem 보통주를 보유하고 있으며, 이는 발행주식 총수의 6.1%에 해당합니다. 주식은 Point72 Associates를 통해 소유되며, Cubist Systematic Strategies가 서브 어드바이저 역할을 합니다. 모든 의결권 및 처분 권한은 공유되며, 단독 보유는 없습니다. 이 신고는 Rule 13d-1(b)/(c)에 따라 수동적 투자임을 나타내며, 지분이 경영권에 영향을 미치기 위해 취득되지 않았음을 인증합니다.

Jason M. Colombo가 2025년 7월 28일 모든 신고자 대표로 서명했습니다. 파생상품이나 추가 증권 종류는 언급되지 않았습니다.

  • 보유 주식: 334만 주
  • 지분 비율: 6.1%
  • 신고자: Point72 Asset Management LP, Point72 Capital Advisors Inc., Steven A. Cohen
  • 목적: 수동적 (Schedule 13G)

Point72 révèle une participation passive de 6,1 % dans Verastem (VSTM)

Le Schedule 13G daté du 25 juillet 2025 indique que Point72 Asset Management LP, son associé général Point72 Capital Advisors Inc., et le fondateur Steven A. Cohen détiennent conjointement 3 338 419 actions ordinaires de Verastem, soit 6,1 % de la classe en circulation. Les actions sont détenues via Point72 Associates, avec Cubist Systematic Strategies agissant en tant que sous-conseiller. Tous les droits de vote et de disposition sont partagés ; aucun n’est détenu individuellement. Le dépôt est effectué conformément à la règle 13d-1(b)/(c), indiquant un investissement passif, et comprend une certification que la participation n’a pas été acquise pour influencer le contrôle.

Jason M. Colombo a signé au nom de toutes les personnes déclarantes le 28 juillet 2025. Aucun dérivé ni autre catégorie de titres n’est mentionné.

  • Actions détenues : 3,34 M
  • Pourcentage de la classe : 6,1 %
  • Personnes déclarantes : Point72 Asset Management LP, Point72 Capital Advisors Inc., Steven A. Cohen
  • Intention : Passive (Schedule 13G)

Point72 gibt eine passive Beteiligung von 6,1 % an Verastem (VSTM) bekannt

Der Schedule 13G vom 25. Juli 2025 zeigt, dass Point72 Asset Management LP, sein General Partner Point72 Capital Advisors Inc. und Gründer Steven A. Cohen gemeinsam 3.338.419 Stammaktien von Verastem halten – das entspricht 6,1 % der ausstehenden Aktienklasse. Die Aktien werden über Point72 Associates gehalten, wobei Cubist Systematic Strategies als Subberater fungiert. Alle Stimm- und Verfügungsrechte werden gemeinsam ausgeübt; keine wird ausschließlich gehalten. Die Meldung erfolgt nach Regel 13d-1(b)/(c), was eine passive Investition bedeutet, und beinhaltet eine Zertifizierung, dass die Beteiligung nicht zum Zweck der Kontrolle erworben wurde.

Jason M. Colombo unterzeichnete am 28. Juli 2025 im Namen aller meldenden Personen. Es werden keine Derivate oder weitere Wertpapierklassen erwähnt.

  • Gehaltene Aktien: 3,34 Mio.
  • Prozentualer Anteil der Klasse: 6,1 %
  • Meldende Personen: Point72 Asset Management LP, Point72 Capital Advisors Inc., Steven A. Cohen
  • Absicht: Passiv (Schedule 13G)
Positive
  • Point72, led by Steven A. Cohen, accumulated 3.34 M shares (6.1 %) of VSTM, signalling institutional confidence and potential liquidity support.
Negative
  • None.

Insights

TL;DR: Point72’s new 6.1 % stake introduces a high-profile, deep-pocketed holder, potentially boosting market confidence without seeking control.

The disclosure positions Verastem among Point72’s portfolio companies, suggesting internal conviction in the biotech’s pipeline. Although 6.1 % is modest in absolute terms, the buyer’s reputation can attract co-investors and improve liquidity. Because the filing is a 13G, Point72 indicates a passive stance; therefore, immediate activist catalysts are unlikely. Still, passive holders sometimes convert to 13D if conviction grows, creating optionality for future engagement. From a valuation perspective, institutional ownership above 5 % can tighten the float, affecting supply-demand dynamics and volatility.

TL;DR: Routine compliance filing; passive classification minimizes governance impact but crosses key 5 % disclosure threshold.

The joint filing clarifies that voting power is shared among three related entities with no sole authority, reducing risk of hidden control efforts. The certification under Item 10 affirms the absence of control intent, aligning with good governance norms. While material as a statutory threshold event, the filing does not alter board composition or strategic direction today.

Point72 rivela una partecipazione passiva del 6,1% in Verastem (VSTM)

Il modulo Schedule 13G datato 25 luglio 2025 mostra che Point72 Asset Management LP, il suo general partner Point72 Capital Advisors Inc. e il fondatore Steven A. Cohen detengono congiuntamente 3.338.419 azioni ordinarie di Verastem, pari al 6,1% della classe azionaria in circolazione. Le azioni sono possedute tramite Point72 Associates, con Cubist Systematic Strategies che agisce come sub-consulente. Tutti i diritti di voto e di disposizione sono condivisi; nessuno è detenuto in modo esclusivo. La comunicazione è effettuata ai sensi della Regola 13d-1(b)/(c), indicando un investimento passivo, e include una certificazione che la partecipazione non è stata acquisita per influenzare il controllo.

Jason M. Colombo ha firmato per conto di tutte le persone segnalanti il 28 luglio 2025. Non sono menzionati derivati o altre classi di titoli.

  • Azioni possedute: 3,34 milioni
  • Percentuale della classe: 6,1%
  • Persone segnalanti: Point72 Asset Management LP, Point72 Capital Advisors Inc., Steven A. Cohen
  • Intento: Passivo (Schedule 13G)

Point72 revela una participación pasiva del 6,1 % en Verastem (VSTM)

El Schedule 13G fechado el 25 de julio de 2025 muestra que Point72 Asset Management LP, su socio general Point72 Capital Advisors Inc. y el fundador Steven A. Cohen poseen conjuntamente 3.338.419 acciones comunes de Verastem, que representan el 6,1 % de la clase en circulación. Las acciones son propiedad de Point72 Associates, con Cubist Systematic Strategies actuando como subasesor. Toda la autoridad de voto y disposición es compartida; ninguna es exclusiva. La presentación se realiza bajo la Regla 13d-1(b)/(c), indicando una inversión pasiva, e incluye una certificación de que la participación no fue adquirida para influir en el control.

Jason M. Colombo firmó en nombre de todas las personas informantes el 28 de julio de 2025. No se mencionan derivados ni otras clases de valores.

  • Acciones poseídas: 3,34 millones
  • Porcentaje de la clase: 6,1 %
  • Personas informantes: Point72 Asset Management LP, Point72 Capital Advisors Inc., Steven A. Cohen
  • Intención: Pasiva (Schedule 13G)

Point72, Verastem(VSTM)에 대한 6.1% 수동 지분 공개

2025년 7월 25일자 Schedule 13G에 따르면 Point72 Asset Management LP, 일반 파트너인 Point72 Capital Advisors Inc., 창립자 Steven A. Cohen이 공동으로 3,338,419주의 Verastem 보통주를 보유하고 있으며, 이는 발행주식 총수의 6.1%에 해당합니다. 주식은 Point72 Associates를 통해 소유되며, Cubist Systematic Strategies가 서브 어드바이저 역할을 합니다. 모든 의결권 및 처분 권한은 공유되며, 단독 보유는 없습니다. 이 신고는 Rule 13d-1(b)/(c)에 따라 수동적 투자임을 나타내며, 지분이 경영권에 영향을 미치기 위해 취득되지 않았음을 인증합니다.

Jason M. Colombo가 2025년 7월 28일 모든 신고자 대표로 서명했습니다. 파생상품이나 추가 증권 종류는 언급되지 않았습니다.

  • 보유 주식: 334만 주
  • 지분 비율: 6.1%
  • 신고자: Point72 Asset Management LP, Point72 Capital Advisors Inc., Steven A. Cohen
  • 목적: 수동적 (Schedule 13G)

Point72 révèle une participation passive de 6,1 % dans Verastem (VSTM)

Le Schedule 13G daté du 25 juillet 2025 indique que Point72 Asset Management LP, son associé général Point72 Capital Advisors Inc., et le fondateur Steven A. Cohen détiennent conjointement 3 338 419 actions ordinaires de Verastem, soit 6,1 % de la classe en circulation. Les actions sont détenues via Point72 Associates, avec Cubist Systematic Strategies agissant en tant que sous-conseiller. Tous les droits de vote et de disposition sont partagés ; aucun n’est détenu individuellement. Le dépôt est effectué conformément à la règle 13d-1(b)/(c), indiquant un investissement passif, et comprend une certification que la participation n’a pas été acquise pour influencer le contrôle.

Jason M. Colombo a signé au nom de toutes les personnes déclarantes le 28 juillet 2025. Aucun dérivé ni autre catégorie de titres n’est mentionné.

  • Actions détenues : 3,34 M
  • Pourcentage de la classe : 6,1 %
  • Personnes déclarantes : Point72 Asset Management LP, Point72 Capital Advisors Inc., Steven A. Cohen
  • Intention : Passive (Schedule 13G)

Point72 gibt eine passive Beteiligung von 6,1 % an Verastem (VSTM) bekannt

Der Schedule 13G vom 25. Juli 2025 zeigt, dass Point72 Asset Management LP, sein General Partner Point72 Capital Advisors Inc. und Gründer Steven A. Cohen gemeinsam 3.338.419 Stammaktien von Verastem halten – das entspricht 6,1 % der ausstehenden Aktienklasse. Die Aktien werden über Point72 Associates gehalten, wobei Cubist Systematic Strategies als Subberater fungiert. Alle Stimm- und Verfügungsrechte werden gemeinsam ausgeübt; keine wird ausschließlich gehalten. Die Meldung erfolgt nach Regel 13d-1(b)/(c), was eine passive Investition bedeutet, und beinhaltet eine Zertifizierung, dass die Beteiligung nicht zum Zweck der Kontrolle erworben wurde.

Jason M. Colombo unterzeichnete am 28. Juli 2025 im Namen aller meldenden Personen. Es werden keine Derivate oder weitere Wertpapierklassen erwähnt.

  • Gehaltene Aktien: 3,34 Mio.
  • Prozentualer Anteil der Klasse: 6,1 %
  • Meldende Personen: Point72 Asset Management LP, Point72 Capital Advisors Inc., Steven A. Cohen
  • Absicht: Passiv (Schedule 13G)





Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)






SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G



Point72 Asset Management, L.P.
Signature:/s/ Jason M. Colombo
Name/Title:Jason M. Colombo, Authorized Person
Date:07/28/2025
Point72 Capital Advisors, Inc.
Signature:/s/ Jason M. Colombo
Name/Title:Jason M. Colombo, Authorized Person
Date:07/28/2025
Steven A. Cohen
Signature:/s/ Jason M. Colombo
Name/Title:Jason M. Colombo, Authorized Person
Date:07/28/2025
Exhibit Information

Exhibit 99.1: Joint Filing Agreement

FAQ

How much of Verastem (VSTM) does Point72 own?

Point72 reports 3,338,419 shares, equal to 6.1 % of the company’s outstanding common stock.

Is the filing a Schedule 13D or 13G?

It is a Schedule 13G, indicating a passive investment rather than an activist intent.

Does Point72 hold sole voting power over the shares?

No. The filing shows 0 shares with sole voting power; all voting and dispositive power is shared.

When was the ownership threshold event for this filing?

The event date triggering disclosure is July 25, 2025.

Who signed the Schedule 13G on behalf of the reporting persons?

Jason M. Colombo signed for Point72 Asset Management, Point72 Capital Advisors, and Steven A. Cohen on 28 Jul 2025.

What is the CUSIP number for Verastem’s common stock?

The CUSIP number disclosed is 92337C203.
Verastem

NASDAQ:VSTM

VSTM Rankings

VSTM Latest News

VSTM Latest SEC Filings

VSTM Stock Data

342.33M
49.81M
1.17%
76.29%
13.4%
Biotechnology
Pharmaceutical Preparations
Link
United States
NEEDHAM